Table 1.
Data from the cardiopulmonary test gathered at T0 in the control Multiple Sclerosis group (MSCTL, n = 10) and in the intervention Multiple Sclerosis group (MSIT, n = 11) group.
| MSCTL | MSIT | p-value | |
|---|---|---|---|
| VO2AT (mL/kg·min−1) | 14.1±5.6 | 13.3±4.3 | 0.71 |
| VEAT(L·min-1) | 28.1±10.5 | 25.4±8.2 | 0.44 |
| HRAT(bpm) | 111.4±25.2 | 111.4±11.11 | 0.99 |
| WAT | 60±24.9 | 57.3±23.7 | 0.79 |
| VO2max(mL/kg·min−1) | 22.2±7.6 | 18.6±7.7 | 0.29 |
| VEmax(L·min−1) | 52.9±2 | 49.5±31.3 | 0.76 |
| HRmax (bpm) | 136.8±24.1 | 136.5±17.4 | 0.97 |
| Wmax | 99±31.8 | 92.7±36.6 | 0.68 |
Parameters were collected at anaerobic threshold and at maximum exercise. Values are mean ± SD.